Search Results 401-410 of 14718 for anti-TNF drugs

1. Emtricitabine, Rilpivirine, And Tenofovir Alafenamide (Oral Route) Description and Brand Names - Mayo Clinic

   This medicine is usually given to patients who have not received any HIV treatment in the past or to replace their current antiviral medicines provided that ...

2. Secukinumab (Intravenous Route, Subcutaneous Route) Proper Use - Mayo Clinic

   This medicine comes with a Medication Guide and patient instructions. Read and follow the instructions carefully. Ask your doctor if you have any questions.

3. Terbutaline (Subcutaneous Route) Precautions - Mayo Clinic

   Drugs and Supplements · Terbutaline (Subcutaneous ... You may also be taking an anti-inflammatory ... Drugs & Supplements; Terbutaline (Subcutaneous ...

4. Azathioprine (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   ... [anti-TNF] agents) within 14 days prior to randomization. Exceptions ... agents, corticosteroids or immunosuppressive drugs). Replacement therapy (e.g. ...

6. Pembrolizumab (Intravenous Route) Description and Brand Names - Mayo Clinic

   Pembrolizumab injection is also used alone as first-line treatment for stage III NSCLC in patients who cannot have surgery or chemotherapy with radiation or for ...

7. CAR-T Cell Therapy Program - Department home - Mayo Clinic

   Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...

8. Tofacitinib (Oral Route) Proper Use - Mayo Clinic

   This medicine should come with a Medication Guide. Read and follow the instructions carefully. Ask your doctor if you have any questions.

9. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... [anti-TNF] agents) ≤ 2 weeks prior to registration. Note: Patients who have ...

10. Umeclidinium And Vilanterol (Inhalation Route) Description and Brand Names - Mayo Clinic

    Inhaled umeclidinium is an anticholinergic. Inhaled vilanterol is a long-acting bronchodilator. Bronchodilators are medicines that are breathed in through the ...